Skip to main content
. 2023 Jan 30;13:1110689. doi: 10.3389/fonc.2023.1110689

Table 2.

Treatment response to conversion therapy based on mRECIST and RECIST1.1.

Overall response mRECIST (n=94) RECIST1.1 (n=94)
Complete response 13 (13.8%) 0
Partial response 69 (73.4%) 25 (26.6%)
Stable disease 6 (6.4%) 63 (67.0%)
Progressive disease 6 (6.4%) 6 (6.4%)
Overall response rate 82 (87.2%) 25 (26.6%)
Disease control rate 88 (93.6%) 88 (93.6%)